The study in the European Respiratory Journal used advanced spatial mapping techniques to compare healthy lung tissues and ...

Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting ...

The next steps for the research team include determining whether the plasma cells are producing autoantibodies against healthy tissues and further investigating how fibroblasts and mural cells develop ...

In accordance with the NMPA approval, Gyre intends to pursue an adaptive Phase 2/3 clinical trial design, combining dose exploration with efficacy confirmation, to efficiently evaluate pirfenidone's ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

Immunohistochemistry of nonfibrotic (left) and IPF (right) lung tissue demonstrating ... expression reduces fibrotic programming of lung fibroblasts. Human lung fibroblasts grown on a stiff ...

Piezo2 is highly expressed in human lung tissue from patients with IPF and in multiple (different) mouse models of lung fibrosis. Piezo2 is highly expressed in primary human lung fibroblasts in ...

the lungs and the brain -- but this particular type of fibroblast seems unique to the lung." Having found the plasma cells in lung tissue taken from people who died of IPF, the team began using ...